Literature DB >> 21160591

Atrial fibrillation and inflammation.

Mehmet Ozaydin1.   

Abstract

Atrial fibrillation (AF) is the most common clinical arrhythmia. Recent investigations have suggested that inflammation might have a role in the pathophysiology of AF. In this review, the association between inflammation and AF, and the effects of several agents that have anti-inflammatory actions, such as statins, polyunsaturated fatty acids, corticosteroids and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, have been investigated.

Entities:  

Keywords:  Atrial fibrillation; Inflammation; Statins

Year:  2010        PMID： 21160591      PMCID： PMC2998823          DOI： 10.4330/wjc.v2.i8.243

Source DB:  PubMed          Journal:  World J Cardiol


  81 in total

1.  Association of statin therapy and the risk of atrial fibrillation in patients with a permanent pacemaker.

Authors:  Guy Amit; Amos Katz; Shikma Bar-On; Harel Gilutz; Avraham Wagshal; Reuven Ilia; Yaakov Henkin
Journal:  Clin Cardiol       Date:  2006-06       Impact factor: 2.882

2.  Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction.

Authors:  Mehmet Ozaydin; Ercan Varol; Yasin Türker; Oktay Peker; Doğan Erdoğan; Abdullah Doğan; Erdoğan Ibrişim
Journal:  Anadolu Kardiyol Derg       Date:  2010-04

3.  Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes.

Authors:  T Morgera; A Di Lenarda; L Dreas; B Pinamonti; F Humar; R Bussani; F Silvestri; D Chersevani; F Camerini
Journal:  Am Heart J       Date:  1992-08       Impact factor: 4.749

4.  Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III.

Authors:  C Michael White; Jeffrey Kluger; Kirkeith Lertsburapa; Osman Faheem; Craig I Coleman
Journal:  Eur J Cardiothorac Surg       Date:  2007-03-12       Impact factor: 4.191

5.  Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.

Authors:  Giuseppe Patti; Massimo Chello; Dario Candura; Vincenzo Pasceri; Andrea D'Ambrosio; Elvio Covino; Germano Di Sciascio
Journal:  Circulation       Date:  2006-09-25       Impact factor: 29.690

6.  Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation.

Authors:  Panagiotis Korantzopoulos; Theofilos M Kolettis; Evaggelos Kountouris; Vasiliki Dimitroula; Pavlos Karanikis; Eugenia Pappa; Konstantinos Siogas; John A Goudevenos
Journal:  Int J Cardiol       Date:  2005-07-10       Impact factor: 4.164

Review 7.  C-reactive protein and other inflammatory risk markers in acute coronary syndromes.

Authors:  Gavin J Blake; Paul M Ridker
Journal:  J Am Coll Cardiol       Date:  2003-02-19       Impact factor: 24.094

Review 8.  Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data.

Authors:  Tim T Issac; Hisham Dokainish; Nasser M Lakkis
Journal:  J Am Coll Cardiol       Date:  2007-11-05       Impact factor: 24.094

9.  Dose-related effect of statins on atrial fibrillation after cardiac surgery.

Authors:  Antonios Kourliouros; Ayesha De Souza; Neil Roberts; Anna Marciniak; Athanasios Tsiouris; Oswaldo Valencia; John Camm; Marjan Jahangiri
Journal:  Ann Thorac Surg       Date:  2008-05       Impact factor: 4.330

10.  Atrial fibrillation following methylprednisolone pulse therapy.

Authors:  N Ueda; T Yoshikawa; M Chihara; S Kawaguchi; Y Niinomi; T Yasaki
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714
View more
  6 in total

1.  Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).

Authors:  Omid Fatemi; Eugene Yuriditsky; Costas Tsioufis; Demetrios Tsachris; Timothy Morgan; Jan Basile; Thomas Bigger; William Cushman; David Goff; Elsayed Z Soliman; Abraham Thomas; Vasilios Papademetriou
Journal:  Am J Cardiol       Date:  2014-07-30       Impact factor: 2.778

2.  Airflow obstruction, lung function, and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Jingjing Li; Sunil K Agarwal; Alvaro Alonso; Saul Blecker; Alanna M Chamberlain; Stephanie J London; Laura R Loehr; Ann Marie McNeill; Charles Poole; Elsayed Z Soliman; Gerardo Heiss
Journal:  Circulation       Date:  2013-12-16       Impact factor: 29.690

3.  Natriuretic Peptides as Predictors of Atrial Fibrillation Recurrences Following Electrical Cardioversion.

Authors:  Theodoros A Zografos; Demosthenes G Katritsis
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11-29

Review 4.  Looking into a conceptual framework of ROS-miRNA-atrial fibrillation.

Authors:  Seahyoung Lee; Eunhyun Choi; Min-Ji Cha; Ki-Chul Hwang
Journal:  Int J Mol Sci       Date:  2014-11-26       Impact factor: 5.923

5.  Time Series Gene Expression Profiling and Temporal Regulatory Pathway Analysis of Angiotensin II Induced Atrial Fibrillation in Mice.

Authors:  Yu-Xuan Wu; Xiao Han; Chen Chen; Lei-Xin Zou; Zhi-Chao Dong; Yun-Long Zhang; Hui-Hua Li
Journal:  Front Physiol       Date:  2019-05-29       Impact factor: 4.566

6.  TLR2 was overexpressed independent of IL-6 in patients with valvular atrial fibrillation.

Authors:  Jian Wang; Lei Xue; Hailong Cao; Fei Cui; Ting Dai; Yijiang Chen
Journal:  J Biomed Res       Date:  2011-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.